MDXG logo

MiMedx Group, Inc. (MDXG) EBITDA

annual EBITDA:

$64.34M+$23.82M(+58.80%)
December 31, 2024

Summary

  • As of today (July 7, 2025), MDXG annual EBITDA is $64.34 million, with the most recent change of +$23.82 million (+58.80%) on December 31, 2024.
  • During the last 3 years, MDXG annual EBITDA has risen by +$66.23 million (+3502.49%).
  • MDXG annual EBITDA is now at all-time high.

Performance

MDXG EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDXGincome statement metrics

quarterly EBITDA:

$12.29M-$1.54M(-11.15%)
March 31, 2025

Summary

  • As of today (July 7, 2025), MDXG quarterly EBITDA is $12.29 million, with the most recent change of -$1.54 million (-11.15%) on March 31, 2025.
  • Over the past year, MDXG quarterly EBITDA has dropped by -$2.24 million (-15.40%).
  • MDXG quarterly EBITDA is now -50.03% below its all-time high of $24.60 million, reached on June 30, 2024.

Performance

MDXG quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDXGincome statement metrics

TTM EBITDA:

$63.34M-$2.24M(-3.41%)
March 31, 2025

Summary

  • As of today (July 7, 2025), MDXG TTM EBITDA is $63.34 million, with the most recent change of -$2.24 million (-3.41%) on March 31, 2025.
  • Over the past year, MDXG TTM EBITDA has increased by +$8.83 million (+16.20%).
  • MDXG TTM EBITDA is now -6.92% below its all-time high of $68.05 million, reached on September 30, 2024.

Performance

MDXG TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDXGincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MDXG EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+58.8%-15.4%+16.2%
3 y3 years+3502.5%+248.7%+1445.4%
5 y5 years+584.1%+202.8%+2266.3%

MDXG EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+702.2%-50.0%+241.2%-6.9%+406.6%
5 y5-yearat high+237.6%-50.0%+176.5%-6.9%+235.5%
alltimeall timeat high+237.6%-50.0%+176.5%-6.9%+235.5%

MDXG EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$12.29M(-11.2%)
$63.34M(-3.4%)
Dec 2024
$64.34M(+58.8%)
$13.84M(+9.7%)
$65.58M(-3.6%)
Sep 2024
-
$12.62M(-48.7%)
$68.05M(+1.0%)
Jun 2024
-
$24.60M(+69.3%)
$67.39M(+23.6%)
Mar 2024
-
$14.53M(-10.9%)
$54.51M(+34.4%)
Dec 2023
$40.52M(-479.2%)
$16.31M(+36.4%)
$40.55M(+11.0%)
Sep 2023
-
$11.96M(+2.0%)
$36.52M(+97.7%)
Jun 2023
-
$11.72M(+1970.0%)
$18.47M(-1046.2%)
Mar 2023
-
$566.00K(-95.4%)
-$1.95M(-81.9%)
Dec 2022
-$10.69M(+465.0%)
$12.29M(-301.5%)
-$10.79M(-47.8%)
Sep 2022
-
-$6.10M(-30.0%)
-$20.66M(+42.3%)
Jun 2022
-
-$8.71M(+5.3%)
-$14.52M(+208.5%)
Mar 2022
-
-$8.27M(-442.9%)
-$4.71M(+148.8%)
Dec 2021
-$1.89M(-96.0%)
$2.41M(+5780.5%)
-$1.89M(-90.0%)
Sep 2021
-
$41.00K(-96.3%)
-$18.85M(-46.1%)
Jun 2021
-
$1.11M(-120.3%)
-$34.96M(-13.1%)
Mar 2021
-
-$5.45M(-62.5%)
-$40.24M(-13.9%)
Dec 2020
-$46.75M(+251.7%)
-$14.55M(-9.4%)
-$46.75M(+32.7%)
Sep 2020
-
-$16.07M(+285.1%)
-$35.22M(+1104.7%)
Jun 2020
-
-$4.17M(-65.1%)
-$2.92M(-78.7%)
Mar 2020
-
-$11.96M(+295.3%)
-$13.74M(+7.2%)
Dec 2019
-$13.29M(-544.3%)
-$3.03M(-118.6%)
-$12.82M(-22.4%)
Sep 2019
-
$16.23M(-208.3%)
-$16.51M(-46.2%)
Jun 2019
-
-$14.99M(+35.8%)
-$30.70M(+145.8%)
Mar 2019
-
-$11.04M(+64.3%)
-$12.49M(-517.3%)
Dec 2018
$2.99M(-94.2%)
-$6.72M(-428.0%)
$2.99M(-90.2%)
Sep 2018
-
$2.05M(-36.4%)
$30.66M(-29.0%)
Jun 2018
-
$3.22M(-27.6%)
$43.16M(-11.5%)
Mar 2018
-
$4.44M(-78.8%)
$48.77M(-6.2%)
Dec 2017
$51.99M(+718.2%)
$20.95M(+44.0%)
$51.99M(+122.4%)
Sep 2017
-
$14.55M(+64.7%)
$23.38M(+55.8%)
Jun 2017
-
$8.84M(+15.4%)
$15.01M(+36.4%)
Mar 2017
-
$7.66M(-200.0%)
$11.00M(+73.1%)
Dec 2016
$6.35M(-76.6%)
-$7.66M(-224.1%)
$6.35M(-71.8%)
Sep 2016
-
$6.17M(+27.9%)
$22.55M(-5.2%)
Jun 2016
-
$4.83M(+60.4%)
$23.80M(-5.8%)
Mar 2016
-
$3.01M(-64.7%)
$25.27M(-6.7%)
DateAnnualQuarterlyTTM
Dec 2015
$27.10M(+193.7%)
$8.54M(+15.1%)
$27.10M(+14.0%)
Sep 2015
-
$7.42M(+17.6%)
$23.78M(+15.2%)
Jun 2015
-
$6.31M(+30.5%)
$20.63M(+42.7%)
Mar 2015
-
$4.83M(-7.4%)
$14.46M(+56.7%)
Dec 2014
$9.22M(-1073.1%)
$5.22M(+22.0%)
$9.22M(+200.1%)
Sep 2014
-
$4.28M(+3240.6%)
$3.07M(-403.1%)
Jun 2014
-
$128.00K(-132.2%)
-$1.01M(-31.5%)
Mar 2014
-
-$397.00K(-57.5%)
-$1.48M(+56.1%)
Dec 2013
-$948.00K(-73.0%)
-$933.30K(-595.6%)
-$947.90K(+54.4%)
Sep 2013
-
$188.30K(-155.8%)
-$614.10K(-84.1%)
Jun 2013
-
-$337.40K(-350.9%)
-$3.86M(+21.2%)
Mar 2013
-
$134.50K(-122.4%)
-$3.19M(-9.2%)
Dec 2012
-$3.51M(-56.0%)
-$599.50K(-80.4%)
-$3.51M(-28.3%)
Sep 2012
-
-$3.06M(-1007.0%)
-$4.90M(+60.3%)
Jun 2012
-
$337.60K(-280.5%)
-$3.06M(-43.0%)
Mar 2012
-
-$187.00K(-90.6%)
-$5.36M(-32.8%)
Dec 2011
-$7.98M(-15.3%)
-$1.99M(+62.9%)
-$7.98M(-2.1%)
Sep 2011
-
-$1.22M(-38.0%)
-$8.15M(-14.2%)
Jun 2011
-
-$1.97M(-29.9%)
-$9.50M(-4.5%)
Mar 2011
-
-$2.81M(+30.0%)
-$9.96M(+5.7%)
Dec 2010
-$9.42M(+30.5%)
-$2.16M(-16.1%)
-$9.42M(+29.7%)
Sep 2010
-
-$2.57M(+6.4%)
-$7.26M(-3.2%)
Jun 2010
-
-$2.42M(+6.5%)
-$7.50M(+8.6%)
Mar 2010
-
-$2.27M(-19.3%)
-$6.91M(-25.5%)
Dec 2009
-$7.22M(-33.7%)
-
-
Sep 2009
-
-$2.81M(+54.1%)
-$9.27M(-5.3%)
Jun 2009
-
-$1.82M(-29.7%)
-$9.79M(-10.1%)
Mar 2009
-
-$2.59M(+27.3%)
-$10.89M(+31.3%)
Mar 2009
-$10.89M(+7.0%)
-
-
Dec 2008
-
-$2.04M(-38.8%)
-$8.29M(+32.4%)
Sep 2008
-
-$3.33M(+13.8%)
-$6.26M(+113.1%)
Jun 2008
-
-$2.93M(>+9900.0%)
-$2.94M(+7884.5%)
Mar 2008
-$10.17M(>+9900.0%)
-
-
Dec 2007
-$36.80K(+128.6%)
-$7400.00(+48.0%)
-$36.80K(+25.2%)
Sep 2007
-
-$5000.00(-41.2%)
-$29.40K(+20.5%)
Jun 2007
-
-$8500.00(-46.5%)
-$24.40K(+53.5%)
Mar 2007
-
-$15.90K
-$15.90K
Dec 2006
-$16.10K
-
-

FAQ

  • What is MiMedx Group, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for MiMedx Group, Inc.?
  • What is MiMedx Group, Inc. annual EBITDA year-on-year change?
  • What is MiMedx Group, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for MiMedx Group, Inc.?
  • What is MiMedx Group, Inc. quarterly EBITDA year-on-year change?
  • What is MiMedx Group, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for MiMedx Group, Inc.?
  • What is MiMedx Group, Inc. TTM EBITDA year-on-year change?

What is MiMedx Group, Inc. annual EBITDA?

The current annual EBITDA of MDXG is $64.34M

What is the all time high annual EBITDA for MiMedx Group, Inc.?

MiMedx Group, Inc. all-time high annual EBITDA is $64.34M

What is MiMedx Group, Inc. annual EBITDA year-on-year change?

Over the past year, MDXG annual EBITDA has changed by +$23.82M (+58.80%)

What is MiMedx Group, Inc. quarterly EBITDA?

The current quarterly EBITDA of MDXG is $12.29M

What is the all time high quarterly EBITDA for MiMedx Group, Inc.?

MiMedx Group, Inc. all-time high quarterly EBITDA is $24.60M

What is MiMedx Group, Inc. quarterly EBITDA year-on-year change?

Over the past year, MDXG quarterly EBITDA has changed by -$2.24M (-15.40%)

What is MiMedx Group, Inc. TTM EBITDA?

The current TTM EBITDA of MDXG is $63.34M

What is the all time high TTM EBITDA for MiMedx Group, Inc.?

MiMedx Group, Inc. all-time high TTM EBITDA is $68.05M

What is MiMedx Group, Inc. TTM EBITDA year-on-year change?

Over the past year, MDXG TTM EBITDA has changed by +$8.83M (+16.20%)
On this page